Gracell Biotechnologies
GRCL
$10.25
Share price
0.00%
Change (1 day)
365.91%
Change (1 year)
Categories
Gracell Biotechnologies (GRCL) - Cash on Hand
Cash on Hand as of September 2023 : $0.23 B
According to Gracell Biotechnologies's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Gracell Biotechnologies - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.21 B | -26.49% |
| 2021-12-31 | $0.28 B | 142.65% |
| 2020-12-31 | $0.11 B | 161.81% |
| 2019-12-31 | $45.27 M | 173.37% |
| 2018-12-31 | $16.56 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -12.68% | 🇺🇸 USA |